Cargando…

Viability assessment and transplantation of fatty liver grafts using end‐ischemic normothermic machine perfusion

End‐ischemic viability testing by normothermic machine perfusion (NMP) represents an effective strategy to recover liver grafts having initially been discarded for liver transplantation (LT). However, its results in the setting of significant (≥30%) macrovesicular steatosis (MaS) have not been speci...

Descripción completa

Detalles Bibliográficos
Autores principales: Patrono, Damiano, De Carlis, Riccardo, Gambella, Alessandro, Farnesi, Francesca, Podestà, Alice, Lauterio, Andrea, Tandoi, Francesco, De Carlis, Luciano, Romagnoli, Renato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106107/
https://www.ncbi.nlm.nih.gov/pubmed/36117430
http://dx.doi.org/10.1002/lt.26574
_version_ 1785026352568598528
author Patrono, Damiano
De Carlis, Riccardo
Gambella, Alessandro
Farnesi, Francesca
Podestà, Alice
Lauterio, Andrea
Tandoi, Francesco
De Carlis, Luciano
Romagnoli, Renato
author_facet Patrono, Damiano
De Carlis, Riccardo
Gambella, Alessandro
Farnesi, Francesca
Podestà, Alice
Lauterio, Andrea
Tandoi, Francesco
De Carlis, Luciano
Romagnoli, Renato
author_sort Patrono, Damiano
collection PubMed
description End‐ischemic viability testing by normothermic machine perfusion (NMP) represents an effective strategy to recover liver grafts having initially been discarded for liver transplantation (LT). However, its results in the setting of significant (≥30%) macrovesicular steatosis (MaS) have not been specifically assessed. Prospectively maintained databases at two high‐volume LT centers in Northern Italy were searched to identify cases of end‐ischemic NMP performed to test the viability of livers with MaS ≥ 30% in the period from January 2019 to January 2022. A total of 14 cases were retrieved, representing 57.9% of NMP and 5.7% of all machine perfusion procedures. Of those patients, 10 (71%) received transplants. Two patients developed primary nonfunction (PNF) and required urgent re‐LT, and both were characterized by incomplete or suboptimal lactate clearance during NMP. PNF cases were also characterized by higher perfusate transaminases, lower hepatic artery and portal vein flows at 2 h, and a lack of glucose metabolism in one case. The remaining eight patients showed good liver function (Liver Graft Assessment Following Transplantation risk score, −1.9 [risk, 13.6%]; Early Allograft Failure Simplified Estimation score, −3.7 [risk, 2.6%]) and had a favorable postoperative course. Overall, NMP allowed successful transplantation of 57% of livers with moderate‐to‐severe MaS. Our findings suggest that prolonged observation (≥6 h) might be required for steatotic livers and that stable lactate clearance is a fundamental prerequisite for their use.
format Online
Article
Text
id pubmed-10106107
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-101061072023-04-17 Viability assessment and transplantation of fatty liver grafts using end‐ischemic normothermic machine perfusion Patrono, Damiano De Carlis, Riccardo Gambella, Alessandro Farnesi, Francesca Podestà, Alice Lauterio, Andrea Tandoi, Francesco De Carlis, Luciano Romagnoli, Renato Liver Transpl Original Articles: Liver Surgery and Organ Preservation End‐ischemic viability testing by normothermic machine perfusion (NMP) represents an effective strategy to recover liver grafts having initially been discarded for liver transplantation (LT). However, its results in the setting of significant (≥30%) macrovesicular steatosis (MaS) have not been specifically assessed. Prospectively maintained databases at two high‐volume LT centers in Northern Italy were searched to identify cases of end‐ischemic NMP performed to test the viability of livers with MaS ≥ 30% in the period from January 2019 to January 2022. A total of 14 cases were retrieved, representing 57.9% of NMP and 5.7% of all machine perfusion procedures. Of those patients, 10 (71%) received transplants. Two patients developed primary nonfunction (PNF) and required urgent re‐LT, and both were characterized by incomplete or suboptimal lactate clearance during NMP. PNF cases were also characterized by higher perfusate transaminases, lower hepatic artery and portal vein flows at 2 h, and a lack of glucose metabolism in one case. The remaining eight patients showed good liver function (Liver Graft Assessment Following Transplantation risk score, −1.9 [risk, 13.6%]; Early Allograft Failure Simplified Estimation score, −3.7 [risk, 2.6%]) and had a favorable postoperative course. Overall, NMP allowed successful transplantation of 57% of livers with moderate‐to‐severe MaS. Our findings suggest that prolonged observation (≥6 h) might be required for steatotic livers and that stable lactate clearance is a fundamental prerequisite for their use. Lippincott Williams & Wilkins 2023-05 2022-10-10 /pmc/articles/PMC10106107/ /pubmed/36117430 http://dx.doi.org/10.1002/lt.26574 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (https://creativecommons.org/licenses/by/4.0/) (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Original Articles: Liver Surgery and Organ Preservation
Patrono, Damiano
De Carlis, Riccardo
Gambella, Alessandro
Farnesi, Francesca
Podestà, Alice
Lauterio, Andrea
Tandoi, Francesco
De Carlis, Luciano
Romagnoli, Renato
Viability assessment and transplantation of fatty liver grafts using end‐ischemic normothermic machine perfusion
title Viability assessment and transplantation of fatty liver grafts using end‐ischemic normothermic machine perfusion
title_full Viability assessment and transplantation of fatty liver grafts using end‐ischemic normothermic machine perfusion
title_fullStr Viability assessment and transplantation of fatty liver grafts using end‐ischemic normothermic machine perfusion
title_full_unstemmed Viability assessment and transplantation of fatty liver grafts using end‐ischemic normothermic machine perfusion
title_short Viability assessment and transplantation of fatty liver grafts using end‐ischemic normothermic machine perfusion
title_sort viability assessment and transplantation of fatty liver grafts using end‐ischemic normothermic machine perfusion
topic Original Articles: Liver Surgery and Organ Preservation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106107/
https://www.ncbi.nlm.nih.gov/pubmed/36117430
http://dx.doi.org/10.1002/lt.26574
work_keys_str_mv AT patronodamiano viabilityassessmentandtransplantationoffattylivergraftsusingendischemicnormothermicmachineperfusion
AT decarlisriccardo viabilityassessmentandtransplantationoffattylivergraftsusingendischemicnormothermicmachineperfusion
AT gambellaalessandro viabilityassessmentandtransplantationoffattylivergraftsusingendischemicnormothermicmachineperfusion
AT farnesifrancesca viabilityassessmentandtransplantationoffattylivergraftsusingendischemicnormothermicmachineperfusion
AT podestaalice viabilityassessmentandtransplantationoffattylivergraftsusingendischemicnormothermicmachineperfusion
AT lauterioandrea viabilityassessmentandtransplantationoffattylivergraftsusingendischemicnormothermicmachineperfusion
AT tandoifrancesco viabilityassessmentandtransplantationoffattylivergraftsusingendischemicnormothermicmachineperfusion
AT decarlisluciano viabilityassessmentandtransplantationoffattylivergraftsusingendischemicnormothermicmachineperfusion
AT romagnolirenato viabilityassessmentandtransplantationoffattylivergraftsusingendischemicnormothermicmachineperfusion